2024 Bristol-myers squibb stock - Bristol-Myers Squibb has increased its dividend for the past 14 consecutive years. When did Bristol-Myers Squibb last increase or decrease its dividend? The most recent change in the company's dividend was an increase of …

 
Bristol Myers Squibb (BMY) has 6 splits in our Bristol Myers Squibb stock split history database. The first split for BMY took place on May 31, 1977. This was a 2 for 1 split, meaning for each share of BMY owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following .... Bristol-myers squibb stock

Bristol forecast that new products would generate at least $10 billion from 2026. (REGIS DUVIGNAU/REUTERS) Bristol-Myers Squibb says it needs more time to meet a major sales target from new drugs ...Sep 26, 2021 · Bristol Myers Squibb (BMY-0.41%) stock hasn't performed very well so far this year. The company will soon face generic competition for top-selling Revlimid. However, it also has several newer ... Bristol-Myers Squibb (BMY). $48.92. 11:04 28/11/23. -0.20% -$0.10. Today's Low ... Bristol-Myers Squibb Market Data. Currency, US Dollars. Share Price, $48.92.Get the latest information on Bristol-Myers Squibb Company (BMY) stock, including its performance, earnings, dividends, and outlook. See the company's ratings, research reports, news, and related articles from Yahoo Finance and Morningstar.Summary. Bristol-Myers Squibb's EBITDA margin is 47.2% at the end of Q1 2022, which is one of the largest values in the pharmaceutical industry. Due to the loss of exclusivity, Revlimid's sales ...NEW YORK--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE:BMY) today reports results for the third quarter of 2022, which reflect strong in-line and new product portfolio growth. “Our strong results reflect growth of our in-line and new product portfolios,” said Giovanni Caforio, M.D., board chair and chief executive officer, Bristol Myers Squibb.. …Share Price. Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The firm offers chemically ...Bristol-Myers Squibb Company (BMY) dividend summary: yield, payout, growth, announce date, ex-dividend date, payout date and Seeking Alpha Premium dividend score.The pharma giant says that on completion of the acquisition, Celgene is now a wholly owned subsidiary of Bristol-Myers Squibb Company, and that under the terms of the merger, Celgene shareholders received for each share, 1.00 share of Bristol-Myers Squibb common stock, $50.00 in cash without interest, as well as one tradeable …In the last 3 months, 4 analysts have offered 12-month price targets for Bristol-Myers Squibb. The company has an average price target of $76.5 with a high of $85.00 and a low of $65.00. Below is ...Bristol-Myers Squibb Co. share price in real-time (850501 / US1101221083), charts and analyses, news, key data, turnovers, company data.About Bristol-Myers Squibb Stock (NYSE:BMY) The Bristol-Myers Squibb Company is a leading global biopharmaceutical company with a long and impressive history of innovating and developing medicines that improve the lives of patients around the world. Founded in 1887 when William McLaren Bristol and John Ripley Myers purchased the Clinton ... Bristol-Myers Squibb Company(NYSE:BMY): : Major stock indices appear heading for weekly gains with the Fed’s first interest rate hike digested easily by investors. However, the market is expected to remain under pressure in the near term. So, because wide-moat companies generally do well in these market conditions, we think cheap wide …According to the issued ratings of 18 analysts in the last year, the consensus rating for Bristol-Myers Squibb stock is Hold based on the current 1 sell rating, 13 hold ratings and 4 buy ratings for BMY. The average twelve-month price prediction for Bristol-Myers Squibb is $63.59 with a high price target of $85.00 and a low price target of $50. ...Bristol-Myers Squibb is forecast to grow earnings and revenue by 11.4% and 0.1% per annum respectively. EPS is expected to grow by 11.9% per annum. Return on equity is forecast to be 46.2% in 3 years.Bristol Myers Squibb (BMY) Com Stk USD 0.10 (CDI) ; Open · $49.36 ; Trade high · $50.18 ; Year high · $81.43 ; Previous close · $49.38 ; Trade low · $48.93.Stock Exchange NYSE Ticker Symbol BMY Full Company Profile Financial Performance In 2022, BMY's revenue was $46.16 billion, a decrease of -0.49% …Bristol Myers stock has lost about a third of its value so far this year. The company declined to make Boerner available for comment on his stock purchase, which …Shares of Bristol Myers Squibb Co. sank 0.24% to $49.98 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...Per Share Data Bristol Myers Squibb Co. All values updated annually at fiscal year end. Earnings Per Share +2.95: Sales 21.51: Tangible Book Value-12.37: ... Stock Movers: Gainers, ...27 thg 7, 2023 ... Bristol Myers Squibb on Thursday said its second-quarter sales fell ... Sales of Eliquis, which Bristol Myers shares with Pfizer (PFE.N) ...Bristol Myers Squibb Co. historical stock charts and prices, analyst ratings, financials, and today’s real-time BMY stock price.Bristol-Myers Squibb insiders own about US$63m worth of shares. That equates to 0.06% of the company. This level of insider ownership is good but just short of being particularly stand-out.Nov 17, 2023 · Bristol Myers Squibb cut its guidance for the sales of new drugs from $10-$13 bln in 2025 to $10+ bln in 2026. The company now lists 9 medications as part of its new product portfolio. They ... Currently, Bristol-Myers Squibb Co’s price-earnings ratio is 12.9. Bristol-Myers Squibb Co’s trailing 12-month revenue is $44.9 billion with a 18.4% profit margin. Year-over-year quarterly sales growth most recently was -2.2%. Analysts expect adjusted earnings to reach $7.550 per share for the current fiscal year.Dec 1, 2023 · Bristol Myers Squibb CEO Chris Boerner just bought a large block of the drug company’s slumping shares. Boerner paid $150,000 on Nov. 28 for 3,071 Bristol Myers shares, an average price of $48. ... Bristol-Myers Squibb · Open. 50.15 · Previous Close. 50.10 · High. 50.45 · Low. 48.93 · 52 Week High. 81.42 · 52 Week Low. 48.25 · Beta. -0.13 · TTM EPS Trend. 7.79 (+ ...The Bristol Myers Squibb 52-week high stock price is 81.42, which is 62.5% above the current share price. The Bristol Myers Squibb 52-week low stock price is 48.25, which is 3.7% below the current share price. The average Bristol Myers Squibb stock price for the last 52 weeks is 64.65. For more information on how our historical price data is ...In the latest trading session, Bristol Myers Squibb (BMY) closed at $65.04, marking a -0.4% move from the previous day. This change was narrower than the S&P 500's daily loss of 0.77%.Bristol Myers Squibb Co. stock underperforms Friday when compared to competitors despite daily gains 12/01/23-3:43AM EST MarketWatch Bristol Myers Squibb new CEO buys company sharesJan 31, 2022 · A top big pharma stock. At a hair under eight times forward earnings, the pharmaceutical giant Bristol Myers Squibb ( BMY 0.69%) is Berkshire's third-cheapest stock holding at the moment. Bristol ... Bristol Myers Squibb (BMY 0.74%) got quite a boost in fourth-quarter revenue from the drugs it received through its acquisition of Celgene. Even looking at an apples-to-apples comparison -- as if ...According to the issued ratings of 18 analysts in the last year, the consensus rating for Bristol-Myers Squibb stock is Hold based on the current 1 sell rating, 13 hold ratings and 4 buy ratings for BMY. The average twelve-month price prediction for Bristol-Myers Squibb is $63.59 with a high price target of $85.00 and a low price target of $50. ...Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products.Detailed statistics for Bristol-Myers Squibb Company (BMY) stock, including valuation metrics, financial numbers, share information and more. Detailed statistics for Bristol-Myers Squibb Company ... Bristol-Myers Squibb Company (BMY) NYSE: BMY · IEX Real-Time Price · USD. Add to Watchlist 50.10 +0.72 (1.46%) At …Currently, Bristol-Myers Squibb Co’s price-earnings ratio is 12.9. Bristol-Myers Squibb Co’s trailing 12-month revenue is $44.9 billion with a 18.4% profit margin. Year-over-year quarterly sales growth most recently was -2.2%. Analysts expect adjusted earnings to reach $7.550 per share for the current fiscal year.On Oct. 8, Bristol Myers announced plans to acquire Mirati Therapeutics. Under the merger agreement, it will cost up to $5.8 billion ($1 billion is contingent on the approval of a new drug ...Bristol-Myers Squibb Company (BMY) dividend growth history: By month or year, chart. Dividend history includes: Declare date, ex-div, record, pay, frequency, amount.In depth view into BMY (Bristol-Myers Squibb) stock including the latest price, news, dividend history, earnings information and financials.Feb 20, 2023 · Bristol-Myers Squibb's current dividend yield of 3.21% is well above the healthcare sector average and in line with many companies in other sectors, such as Exxon Mobil and Chevron Corporation . Description. Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U ...23 thg 12, 2022 ... Bristol Myers Squibb stock (NYSE: BMY) has seen an 18% rise this year, far better than the broader S&P500 index, which is down 20%.3 thg 1, 2019 ... Under the terms of the agreement, Celgene shareholders will receive 1.0 Bristol-Myers Squibb share and $50.00 in cash for each share of Celgene.Forward-looking statements contained on this website should be evaluated together with the many uncertainties that affect Bristol Myers Squibb's business, particularly those identified in the cautionary factors discussion in the company’s most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.Bristol Myers Squibb (NYSE: BMY) today announced that on December 10, 2021, its Board of Directors approved an increase in the quarterly dividend and authorized an additional multi-year share repurchase program. “The company’s financial position is strong, and we remain committed to a consistent, balanced capital allocation strategy,” …NEW YORK--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE:BMY) today reports results for the fourth quarter and full year of 2022, which reflect robust growth of the in-line and new product portfolios, driven by strong commercial execution and continued progress of the company's pipeline. “2022 was a successful year for our company, one of …34,300. Chris Boerner. https://www.bms.com. Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company’s …Reconciliations of these non-GAAP financial measures to the most comparable GAAP measures for a particular quarterly period are available on the company’s website at www.bms.com . Discover the stock split history of Bristol Myers Squibb and other stock-related corporate actions taken in the past.Aug 29, 2022 · Bristol Myers Squibb (BMY-0.41%) stock was down by a noteworthy 5.4% as of 1:32 p.m. ET Monday afternoon. Bristol's share price is in retreat mode today after the company announced over the ... Find real-time BMY - Bristol-Myers Squibb Co stock quotes, company profile, news and forecasts from CNN Business. ... Bristol-Myers Squibb Co (NYSE:BMY) 48.73. …Historical stock closing prices for Bristol-Myers Squibb Company (BMY). See each day's opening price, high, low, close, volume, and change %.Nov 20, 2023 · Bristol-Myers Squibb (NYSE: BMY) stock is falling on Monday after a couple of updates that are weighing on BMY shares today. The first bit of news worth noting is the results from a clinical trial ... Within the last quarter, Bristol-Myers Squibb (NYSE:BMY) has observed the following analyst ratings: These 15 analysts have an average price target of $63.13 versus the current price of Bristol ...Executive severance benefits. Patients & Caregivers. UK-CA Slavery and Human Trafficking Statement (PDF) Forward-Looking Statement. Worldwide Locations. Contact Us. Learn more about Bristol Myers Squibb's policies on executive compensation, stock option repricing, stockholder rights, compliance violations and severance benefits.Bristol Myers Squibb pushed back its sales expectations for its new drugs by a year early Thursday, and BMY stock tumbled. The company expects its new drugs to reach $10 billion in sales by 2026.Mar 11, 2023 · To that point, Bristol Myers stock trades at $65 per share and just 8.2X forward earnings which is nicely below its industry average of 18X and the S&P 500’s 17.9X. Similarly, CVS trades at 8.7X ... Bristol-Myers Squibb Company (BMY) dividend summary: yield, payout, growth, announce date, ex-dividend date, payout date and Seeking Alpha Premium dividend score.3.64B. -4.79%. Get the latest Bristol-Myers Squibb Co (BMY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment... Summary. Bristol-Myers Squibb's EBITDA margin is 47.2% at the end of Q1 2022, which is one of the largest values in the pharmaceutical industry. Due to the loss of exclusivity, Revlimid's sales ...Executive severance benefits. Patients & Caregivers. UK-CA Slavery and Human Trafficking Statement (PDF) Forward-Looking Statement. Worldwide Locations. Contact Us. Learn more about Bristol Myers Squibb's policies on executive compensation, stock option repricing, stockholder rights, compliance violations and severance benefits.Find the latest analyst research for Bristol-Myers Squibb Company Common Stock (BMY) at Nasdaq.com.Find out the direct holders, institutional holders and mutual fund holders for Bristol-Myers Squibb Company (BMY).1-855-598-5485 toll-free within the U.S. 1-651-450-4064 from outside the U.S. A telecommunications relay service should be used by the hearing impaired when calling the telephone numbers above. To contact in writing: EQ Shareowner Services. 1110 Centre Pointe Curve, Suite 101.Bristol-Myers Squibb Stock Price, News & Analysis (NYSE:BMY) $49.38 +0.66 (+1.35%) (As of 05:38 PM ET) Compare Today's Range $48.25 $49.40 50-Day Range $48.48 …Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. At Bristol Myers Squibb, we believe in the power of science to address some of the most challenging diseases of our time. Our focus on these unmet needs comes during ...Bristol Myers Squibb Co. Watch list NEW Set a price target alert After Hours Last Updated: Dec 1, 2023 7:59 p.m. EST Delayed quote $ 50.17 0.07 0.14% After Hours Volume: 403.99K Advanced Charting... SOPA Images/LightRocket via Getty Images. Bristol Myers Squibb stock (NYSE: BMY) is up 15% in a month, slightly outperforming the broader S&P500 index, up 11%. The rise in BMY stock can be ...Valuation metrics show that Bristol Myers Squibb Company may be undervalued. Its Value Score of A indicates it would be a good pick for value investors. The financial health and growth prospects ...The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb ( BMS ), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, [1] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.Bristol-Myers Squibb Company published this content on 29 April 2022 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 29 April 2022 13:56:04 UTC .26 thg 9, 2022 ... ... share the common bond of being patients. Hear how Evris uses what he ... Bristol Myers Squibb | Flexible Ways of Working. Bristol Myers Squibb ...Bristol-Myers Squibb Company's has been growing its dividend for 7.0 years at a rate of 7.34% per year for the last 5 years (CAGR). You can view Bristol-Myers ...Bristol-Myers Squibb Company Common Stock. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is ...Bristol Myers Squibb Co. historical stock charts and prices, analyst ratings, financials, and today’s real-time BMY stock price. Business Insights & Analytics. Cell Therapy (CAR T) Contract Positions. Devens. Drug Discovery and Translational Medicine. Immunology. Medical Science Liaison. Military and Veterans. Oncology R&D.Complete Bristol Myers Squibb Co. stock information by Barron's. View real-time BMY stock price and news, along with industry-best analysis.The value of US pharma Bristol Myers Squibb's ( NYSE: BMY) stock has decreased by -2% over the past 12 months after building some real momentum last year, reaching a price of $69 by late August ...Find the latest Bristol-Myers Squibb Company (BMY) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.The all-time high Bristol Myers Squibb stock closing price was 77.65 on December 02, 2022. · The Bristol Myers Squibb 52-week high stock price is 81.24, which is ...17.04M (132.72% of Avg) Complete Bristol Myers Squibb Co. stock information by Barron's. View real-time BMY stock price and news, along with industry-best analysis.Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products.Feb 26, 2023 · New York-based Bristol-Myers Squibb (BMY-0.41%) is among the largest pharmaceutical companies in the world. And its stock is a no-brainer buy for investors seeking reliable dividend income. Bristol Myers Squibb BMY expects its 2023 revenue to rise 2% and earnings to be $8.10 (at the mid-point of its range) on a per share and adjusted basis, reflecting a 5% y-o-y growth. This is ...Bristol-Myers Squibb's stock is down 40% despite a market increase of 20%. Read here why we think BMY may be undervalued. Bristol-Myers Squibb's stock is down 40% despite a market increase of 20%.Bristol-Myers Squibb reported $2.44B in Stock for its fiscal quarter ending in September of 2023. Data for Bristol-Myers Squibb | BMY - Stock including ...Bristol Myers Squibb recognizes our responsibility to benefit the communities we serve. During 2022, we further deepened our commitment to our environmental, ... 4 Includes $4.6 billion for dividends paid and $8.0 billion for common stock repurchases. early-stage assets in development high potential mid-late stage registrational assets across ...Discover historical prices for BMY stock on Yahoo Finance. View daily, weekly or monthly format back to when Bristol-Myers Squibb Company stock was issued.Historical daily share price chart and data for Bristol Myers Squibb since 1972 adjusted for splits and dividends. The latest closing stock price for Bristol Myers Squibb as of December 01, 2023 is 50.10.. The all-time high Bristol Myers Squibb stock closing price was 77.65 on December 02, 2022.; The Bristol Myers Squibb 52-week high stock price …Bristol-myers squibb stock

Bristol Myers Squibb missed analysts' Q1 estimates for both the top and bottom lines. Revenue rose 3% year over year to $11.1 billion, a little short of the consensus Wall Street estimate of $11. .... Bristol-myers squibb stock

bristol-myers squibb stock

About Bristol-Myers Squibb Stock (NYSE:BMY) The Bristol-Myers Squibb Company is a leading global biopharmaceutical company with a long and impressive history of innovating and developing medicines that improve the lives of patients around the world. Founded in 1887 when William McLaren Bristol and John Ripley Myers purchased the Clinton ...The average price target for Bristol-Myers Squibb is $60.69. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $72.00 ,the lowest forecast is $50.00. The average price target represents 17.80% Increase from the current price of $51.52.Stock Price Forecast. According to 17 stock analysts, the average 12-month stock price forecast for BMY stock stock is $64.65, which predicts an increase of 32.70%. The lowest target is $50 and the highest is $85. On …BRISTOL-MYERS SQUIBB CO 0R1F Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals.Bristol Myers Squibb CEO Chris Boerner just bought a large block of the drug company’s slumping shares. Boerner paid $150,000 on Nov. 28 for 3,071 Bristol Myers shares, an average price of $48. ...1-855-598-5485 toll-free within the U.S. 1-651-450-4064 from outside the U.S. A telecommunications relay service should be used by the hearing impaired when calling the telephone numbers above. To contact in writing: EQ Shareowner Services. 1110 Centre Pointe Curve, Suite 101.Based on the closing price of Bristol-Myers Squibb stock of $52.43 on January 2, 2019, the cash and stock consideration to be received by Celgene shareholders at closing is valued at $102.43 per Celgene share and one CVR (as …Bristol Myers Squibb CEO Chris Boerner just bought a large block of the drug company’s slumping shares. Boerner paid $150,000 on Nov. 28 for 3,071 Bristol Myers shares, an average price of $48. ...Stock analysis for Bristol-Myers Squibb Co (BMY:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.1-800-721-5072. (toll free U.S. only) As of 2019, Bristol Myers Squibb and Celgene have merged. If you or someone you know have possibly experienced a side effect or have a product complaint while taking a legacy Celgene product, please contact us. …Buy or sell recommendation and investment advice on Bristol Myers. Macroaxis investing advice on Bristol Myers Squibb is currently Strong Buy. We provides investment advice on Bristol Myers Stock only from the perspective of investor risk tolerance and investment horizon. Note, investing in any Stock, including Bristol Myers Squibb, involves risk and …Bristol Myers Squibb CEO Chris Boerner just bought a large block of the drug company’s slumping shares. Boerner paid $150,000 on Nov. 28 for 3,071 Bristol Myers shares, an average price of $48. ...Find real-time BMY - Bristol-Myers Squibb Co stock quotes, company profile, news and forecasts from CNN Business. ... Bristol-Myers Squibb Co (NYSE:BMY) 48.73. …The average price target for Bristol-Myers Squibb is $60.69. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $72.00 ,the lowest forecast is $50.00. The average price target represents 17.80% Increase from the current price of $51.52.Bristol-Myers Squibb reported $2.44B in Stock for its fiscal quarter ending in September of 2023. Data for Bristol-Myers Squibb | BMY - Stock including ...Currently, Bristol-Myers Squibb Co’s price-earnings ratio is 12.9. Bristol-Myers Squibb Co’s trailing 12-month revenue is $44.9 billion with a 18.4% profit margin. Year-over-year quarterly sales growth most recently was -2.2%. Analysts expect adjusted earnings to reach $7.550 per share for the current fiscal year.To that point, Bristol Myers stock trades at $65 per share and just 8.2X forward earnings which is nicely below its industry average of 18X and the S&P 500’s 17.9X. Similarly, CVS trades at 8.7X ...Real-Time News, Market Data and Stock Quote for Bristol-Myers Squibb.Bristol-Myers Squibb stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.To that point, Bristol Myers stock trades at $65 per share and just 8.2X forward earnings which is nicely below its industry average of 18X and the S&P 500’s 17.9X. Similarly, CVS trades at 8.7X ...Bristol Myers Squibb missed analysts' Q1 estimates for both the top and bottom lines. Revenue rose 3% year over year to $11.1 billion, a little short of the consensus Wall Street estimate of $11. ...Stay up to date on how Bristol-Myers Squibb Co (BMY:XNYS) stock has performed compared to similar stocks in the same industry on a daily, quarterly, and monthly basis.26 thg 10, 2023 ... Bristol Myers narrowed its full-year adjusted earnings outlook to $7.50 to $7.65 per share, from a previous forecast of $7.35 to $7.65 a share.Bristol-Myers Squibb's stock is down 40% despite a market increase of 20%. Read here why we think BMY may be undervalued.Bristol Myers agrees to pay Avidity $60 million in cash and also will purchase about $40 million of Avidity common stock at $7.88 a share. ... deal with Bristol Myers Squibb. Avidity stock was ...Stock analysis for Bristol-Myers Squibb Co (BMY:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Under the terms of the merger, Celgene shareholders received for each share, 1.00 share of Bristol-Myers Squibb common stock, $50.00 in cash without interest and one tradeable Contingent Value Right (CVR), which will entitle the holder to receive a payment of $9.00 in cash if certain future regulatory milestones are achieved.Find out the direct holders, institutional holders and mutual fund holders for Bristol-Myers Squibb Company (BMY).View live Bristol-Myers Squibb Company chart to track its stock's price action. Find market predictions, BMY financials and market news.Nov 21, 2023 · Summary. Bristol-Myers Squibb Company is facing challenges due to the loss of exclusivity of its drug Revlimid and the need for new product growth. The company made a transformative deal with the ... According to the issued ratings of 18 analysts in the last year, the consensus rating for Bristol-Myers Squibb stock is Hold based on the current 1 sell rating, 13 hold ratings and 4 buy ratings for BMY. The average twelve-month price prediction for Bristol-Myers Squibb is $63.59 with a high price target of $85.00 and a low price target of $50. ...Get Bristol-Myers Squibb Co (BMY.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsFind out the direct holders, institutional holders and mutual fund holders for Bristol-Myers Squibb Company (BMY).Bristol Myers Squibb (BMY 0.74%) got quite a boost in fourth-quarter revenue from the drugs it received through its acquisition of Celgene. Even looking at an apples-to-apples comparison -- as if ...Bristol Myers Squibb Co. analyst ratings, historical stock prices, earnings estimates & actuals. BMY updated stock price target summary.PROFILE (BMY). Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical ...Bristol Myers' Q3 results indicate a more challenging recovery than previously communicated, leading to a downgrade in its medium-term outlook. Read …A top big pharma stock. At a hair under eight times forward earnings, the pharmaceutical giant Bristol Myers Squibb ( BMY 0.69%) is Berkshire's third-cheapest stock holding at the moment. Bristol ...Bristol Myers Squibb (BMY) closed at $67.24 in the latest trading session, marking a -0.4% move from the prior day. This move was narrower than the S&P 500's daily loss of 1.65%.It's good to see that Bristol-Myers Squibb's EPS has grown from US$2.84 to US$3.48 over twelve months. That's a 22% gain; respectable growth in the broader scheme of things. Careful consideration ...Bristol-Myers Squibb ( BMY 1.35%) is a top healthcare company with a rich history that goes back to the 1800s. But its business, and its stock, have been underperforming recently. Share prices of ...Given the large stake in the stock by institutions, Bristol-Myers Squibb's stock price might be vulnerable to their trading decisions A total of 25 investors have a majority stake in the company ...Bristol Myers Squibb ( BMY 1.46%), or BMS for short, is starting the week off on a sour note. Specifically, the drugmaker's shares fell by as much as 4% in early action Monday. BMS' stock has ...The next Bristol-Myers Squibb Co. dividend is expected to go ex in 1 month and to be paid in 2 months. The previous Bristol-Myers Squibb Co. dividend was 57c and it went ex 2 months ago and it was paid 1 month ago. There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 1.4.Compared to the current market price of 49.835 USD , Bristol-Myers Squibb Co is Undervalued by 45%. ALPHA SPREAD. Join 87,600+ value investors using Alpha Spread. Create a free account. or see our plans & pricing. Bristol-Myers Squibb Co (NYSE:BMY) Intrinsic Valuation. Check if BMY is overvalued or undervalued under the bear, base, and …Feb 20, 2023 · Bristol-Myers Squibb's current dividend yield of 3.21% is well above the healthcare sector average and in line with many companies in other sectors, such as Exxon Mobil and Chevron Corporation . Find answers to the most commonly asked questions by shareholders about the Celgene acquisition and Celgene shares.Bristol-Myers Squibb · Open. 50.15 · Previous Close. 50.10 · High. 50.45 · Low. 48.93 · 52 Week High. 81.42 · 52 Week Low. 48.25 · Beta. -0.13 · TTM EPS Trend. 7.79 (+ ...Sep 28, 2021 · 21 Day Returns. Trefis [Updated: Aug 30, 2021] BMY Stock Decline. The stock price of Bristol Myers Squibb (NYSE: BMY) has seen a 4% drop over the last five trading sessions led by a recent sell ... 3 thg 1, 2019 ... Under the terms of the agreement, Celgene shareholders will receive 1.0 Bristol-Myers Squibb share and $50.00 in cash for each share of Celgene.Bristol-Myers Squibb Stock Price, News & Analysis (NYSE:BMY) $49.38 +0.66 (+1.35%) (As of 05:38 PM ET) Compare Today's Range $48.25 $49.40 50-Day Range $48.48 …Bristol Myers' Q3 results indicate a more challenging recovery than previously communicated, leading to a downgrade in its medium-term outlook. Read …Annual Balance Sheet. Fiscal Year End for Bristol Myers Squibb Company falls in the month of December. All items in Millions except Per Share data. BMY: Bristol Myers Squibb balance sheet. Get the ...Find the latest Bristol-Myers Squibb Company (BMY) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Bristol Myers Squibb Co. historical stock charts and prices, analyst ratings, financials, and today’s real-time BMY stock price.Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of forty-nine cents ($0.49) per share on the $.10 par value common stock of the company. The dividend is payable on November 1, 2021 to stockholders of record at the close of business on October 1, 2021. In addition, the Board …Bristol-Myers Squibb stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.Bristol-Myers Squibb Company (BMY.NYSE) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Bristol-Myers Squibb Company ...Bristol-Myers Squibb Stock Price, News & Analysis (NYSE:BMY) $49.38 +0.66 (+1.35%) (As of 05:38 PM ET) Compare Today's Range $48.25 $49.40 50-Day Range $48.48 …Find the latest historical data for Bristol-Myers Squibb Company Common Stock (BMY) at Nasdaq.com. . Best apps for penny stocks